Extensive Assessment of Underlying Etiological Factors in Primary Infertile Men Reduces the Proportion of Men With Idiopathic Infertility.


Journal

Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782

Informations de publication

Date de publication:
2021
Historique:
received: 24 10 2021
accepted: 03 12 2021
entrez: 10 1 2022
pubmed: 11 1 2022
medline: 19 2 2022
Statut: epublish

Résumé

Up to 40% of infertile men remain without a recognized cause (i.e., idiopathic infertility). We aimed to identify, categorize, and report the supposed causes of male infertility in a cohort of white-European men presenting for primary couple's infertility, by using a thorough and extensive baseline diagnostic work-up. Cross-sectional study of 1,174 primary infertile men who underwent a thorough diagnostic work-up including: detailed medical history, physical examination, hormonal assessment, genetic testing, semen analyses; semen and urine cultures; testis color Duplex US. Men without any identified causal factor were considered as idiopathic. Six different etiological categories were established, and their prevalence was estimated. Logistic regression models estimated the risk of missing causal identification. A possible causal factor was identified in 928 (81%) men. Hypogonadism was the most frequent identified cause (37%), followed by varicocele (27%). Genetic abnormalities were found in 5% of patients. A causal factor was more easily identifiable for the more severe infertility cases, and azoospermic men were those less likely to be defined as idiopathic (OR and 95% CIs: 0.09; 0.04-0.20). Relative proportion of identified causes remained constant during the 10-year study period (p>0.43). Due to a more comprehensive and extensive diagnostic work-up, at least one underlying cause of male infertility factor in 4 out of 5 infertile men can be identified. Men with a less severe phenotype remain a clinical challenge in terms of establishing a possible etiologic factor. Further studies are needed to assess which subset of infertile men deserves a more extensive work-up.

Identifiants

pubmed: 35002977
doi: 10.3389/fendo.2021.801125
pmc: PMC8739963
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

801125

Informations de copyright

Copyright © 2021 Ventimiglia, Pozzi, Capogrosso, Boeri, Alfano, Cazzaniga, Matloob, Abbate, Viganò, Montorsi and Salonia.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Am J Public Health. 2005;95 Suppl 1:S144-50
pubmed: 16030331
Lancet Diabetes Endocrinol. 2017 Jul;5(7):544-553
pubmed: 27395771
J Clin Endocrinol Metab. 2010 Apr;95(4):1810-8
pubmed: 20173018
Eur Urol. 2016 Dec;70(6):920-923
pubmed: 27343001
Fertil Steril. 2016 Nov;106(6):1338-1343
pubmed: 27526630
J Androl. 2002 Jan-Feb;23(1):18-22; discussion 44-5
pubmed: 11780918
Cochrane Database Syst Rev. 2016 Mar 31;3:CD011034
pubmed: 27031818
Hum Reprod. 2012 Jan;27(1):36-43
pubmed: 22081244
Eur Urol Focus. 2020 Jan 15;6(1):178-183
pubmed: 30082228
Cochrane Database Syst Rev. 2008 Jul 16;(3):CD000479
pubmed: 18646066
Metabolism. 2013 Apr;62(4):457-78
pubmed: 22999785
Fertil Steril. 2016 Oct;106(5):1076-1082.e1
pubmed: 27473348
Fertil Steril. 2015 Jan;103(1):66-71
pubmed: 25497466
Pediatr Endocrinol Rev. 2009 Jun;6(4):476-80
pubmed: 19550382
Fertil Steril. 2015 Jul;104(1):48-55
pubmed: 26006735
Andrology. 2017 May;5(3):505-510
pubmed: 28409903
Fertil Steril. 2017 Jan;107(1):74-82.e7
pubmed: 27793385
Eur J Endocrinol. 2015 Jun;172(6):669-76
pubmed: 25740852
Eur Urol. 2006 Feb;49(2):258-63
pubmed: 16426727
Lancet Diabetes Endocrinol. 2017 Jul;5(7):554-564
pubmed: 27395770
Eur Urol Focus. 2019 Nov;5(6):1146-1151
pubmed: 29731401
Hum Reprod. 2017 Jan;32(1):18-31
pubmed: 27864361
N Engl J Med. 2007 May 3;356(18):1835-41
pubmed: 17476009
Physiol Rev. 2016 Jan;96(1):55-97
pubmed: 26582516
Andrology. 2016 Sep;4(5):944-51
pubmed: 27368157

Auteurs

Eugenio Ventimiglia (E)

Division of Experimental Oncology/Unit of Urology, Urological Research Institute (URI), Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Ospedale San Raffaele, Milan, Italy.
Department of Urology, University Vita-Salute San Raffaele, Milan, Italy.

Edoardo Pozzi (E)

Division of Experimental Oncology/Unit of Urology, Urological Research Institute (URI), Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Ospedale San Raffaele, Milan, Italy.
Department of Urology, Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Fondazione Ca' Granda - Ospedale Maggiore Policlinico, University of Milan, Milan, Italy.

Paolo Capogrosso (P)

Division of Experimental Oncology/Unit of Urology, Urological Research Institute (URI), Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Ospedale San Raffaele, Milan, Italy.
Department of Urology, University Vita-Salute San Raffaele, Milan, Italy.

Luca Boeri (L)

Division of Experimental Oncology/Unit of Urology, Urological Research Institute (URI), Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Ospedale San Raffaele, Milan, Italy.
Department of Urology, Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Fondazione Ca' Granda - Ospedale Maggiore Policlinico, University of Milan, Milan, Italy.

Massimo Alfano (M)

Division of Experimental Oncology/Unit of Urology, Urological Research Institute (URI), Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Ospedale San Raffaele, Milan, Italy.

Walter Cazzaniga (W)

Division of Experimental Oncology/Unit of Urology, Urological Research Institute (URI), Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Ospedale San Raffaele, Milan, Italy.
Department of Urology, University Vita-Salute San Raffaele, Milan, Italy.

Rayan Matloob (R)

Division of Experimental Oncology/Unit of Urology, Urological Research Institute (URI), Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Ospedale San Raffaele, Milan, Italy.

Costantino Abbate (C)

Division of Experimental Oncology/Unit of Urology, Urological Research Institute (URI), Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Ospedale San Raffaele, Milan, Italy.

Paola Viganò (P)

Infertility Unit, Unit of Obstetrics/Gynecology, Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Ospedale San Raffaele, Milan, Italy.

Francesco Montorsi (F)

Division of Experimental Oncology/Unit of Urology, Urological Research Institute (URI), Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Ospedale San Raffaele, Milan, Italy.
Department of Urology, University Vita-Salute San Raffaele, Milan, Italy.

Andrea Salonia (A)

Division of Experimental Oncology/Unit of Urology, Urological Research Institute (URI), Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Ospedale San Raffaele, Milan, Italy.
Department of Urology, University Vita-Salute San Raffaele, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH